Patents Assigned to Universite de Droit et de la Sante Lille 2
  • Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
    Patent number: 9945873
    Abstract: The present invention relates to methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient. More particularly, the present invention relates to a method for predicting the risk of having an organ failure selected from the group consisting of respiratory failure, renal failure and thrombopenia in a septic patient comprising a step consisting of measuring the concentration of endocan in a blood sample obtained from said septic patient.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: April 17, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE DROIT ET DE LA SANTE LILLE 2, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
    Inventor: Philippe Lassalle
  • METHODS AND KITS FOR PREDICTING THE RISK OF RESPIRATORY FAILURE, RENAL FAILURE OR THROMBOPENIA IN A SEPTIC PATIENT BY MEASURING ENDOCAN LEVELS IN BLOOD
    Publication number: 20140017707
    Abstract: The present invention relates to methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient. More particularly, the present invention relates to a method for predicting the risk of having an organ failure selected from the group consisting of respiratory failure, renal failure and thrombopenia in a septic patient comprising a step consisting of measuring the concentration of endocan in a blood sample obtained from said septic patient.
    Type: Application
    Filed: January 20, 2012
    Publication date: January 16, 2014
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), Centre Hospitalier Regional Universitaire de Lille, Universite de Droit et de la Sante Lille 2
    Inventor: Philippe Lassalle